[RadioTransNet, the French network for preclinical research in oncological radiotherapy].. RadioTransNet, le réseau national de radiothérapie oncologique préclinique

Archive ouverte

Bayart, Elsa | Azria, D. | Balosso, J. | Benderitter, M. | Cohen-Jonathan Moyal, E. | Delpon, G. | Deutsch, E. | Lacornerie, T. | Romeo, P.H. | Marchesi, V. | Maingon, P.

Edité par CCSD ; Elsevier Masson -

International audience. The ambition of the RADIOTRANSNET network, launched by the INCa at the end of 2018, is to create a French research consortium dedicated to preclinical radiotherapy to foster scientific and clinical interactions at the interface of radiotherapy and radiobiology, and to identify research priorities dedicated to innovation in radiotherapy. The activities of the network are organized around four major axes that are target definition, normal tissue, combined treatments and dose modelling. Under the supervision of the Scientific Council, headed by a coordinator designated by the SFRO and a co-coordinator designated by the SFPM, three leaders coordinate each axis: a radiation-oncologist, a medical physicist and a biologist, who are responsible for organizing a scientific meeting based on the consensus conference methodology to identify priority issues. The selected themes will be the basis for the establishment of a strategic research agenda and a roadmap to help coordinate national basic and translational research efforts in oncological radiotherapy. This work will be published and will be transmitted to the funding institutions and bodies with the aim of opening dedicated calls to finance the necessary human and technical resources. Structuration of a preclinical research network will allow coordinating the efforts of all the actors in the field and thus promoting innovation in radiotherapy.

Consulter en ligne

Suggestions

Du même auteur

RadioTransNet: Preclinical research network coordinated at the SFRO and SFPM

Archive ouverte | Maingon, P. | CCSD

International audience

Fast dose fractionation using ultra-short laser accelerated proton pulses can increase cancer cell mortality, which relies on functional PARP1 protein

Archive ouverte | Bayart, Elsa | CCSD

International audience. Radiotherapy is a cornerstone of cancer management. The improvement of spatial dose distribution in the tumor volume by minimizing the dose deposited in the healthy tissues have been a major ...

Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis

Archive ouverte | Monceau, V. | CCSD

International audience. Background Cardiac toxicity is a side-effect of anti-cancer treatment including radiotherapy and this translational study was initiated to characterize radiation-induced cardiac side effects ...

Chargement des enrichissements...